We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
신규 편입 · 포트폴리오 비중 0.03%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $25.15 · 20 analysts
Stored first · Google News · Yahoo Finance (English)
Doximity (NYSE:DOCS) Upgraded at Zacks Research - MarketBeat
Doximity (NYSE:DOCS) Upgraded at Zacks Research MarketBeat
Form 4 Doximity Inc For: 14 July By Investing.com - Investing.com Canada
Form 4 Doximity Inc For: 14 July By Investing.com Investing.com Canada
Doximity (DOCS) director receives 9,750 RSUs as committee voids part of prior grant - Stock Titan
Doximity (DOCS) director receives 9,750 RSUs as committee voids part of prior grant Stock Titan
Equity grant: Doximity (NYSE: DOCS) gives 21,314 RSUs to director - Stock Titan
Equity grant: Doximity (NYSE: DOCS) gives 21,314 RSUs to director Stock Titan
Doximity (DOCS) Q4 2026 earnings summary - Quartr
Doximity (DOCS) Q4 2026 earnings summary Quartr
Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investors Yahoo Finance
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $0.3 | — | — | $151.52M | — | Scheduled |
| FY2026 Q3 | 2024. 12. 31. | Time TBD | — | $0.8 | — | — | $432.11M | Reported |
| FY2026 Q2 | 2024. 09. 30. | Time TBD | — | $0.43 | — | — | $263.51M | Reported |
| FY2026 Q1 | 2024. 06. 30. | Time TBD | — | $0.21 | — | — | $126.68M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 16. | Goldman Sachs | — | Maintain | Neutral → Neutral | — | Goldman Sachs: Neutral |
| 2026. 05. 15. | Barclays | — | Downgrade | Overweight → Equal-Weight | — | Barclays: Overweight → Equal-Weight |
| 2026. 05. 15. | Leerink Partners | — | Maintain | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2026. 05. 15. | Jefferies | — | Downgrade | Buy → Hold | — | Jefferies: Buy → Hold |
| 2026. 05. 15. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 05. 15. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
As of FY2026Q3 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 1,370,153 | $31.92M | 0.03% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 29,050 | $1.29M | 0.00% | — | New position |